XT
CUE icon

XTX Topco’s Cue Biopharma CUE Stock Holding History

XTX Topco’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-504
Closed -$3.48K – 4232
2026
Q1 		$3.48K Buy
+504
New +$4.7K ﹤0.01% 3762
2025
Q4 		– Sell
-491
Closed -$10.6K – 3398
2025
Q3 		$10.6K Sell
491
-259
-35% -$6.08K ﹤0.01% 2438
2025
Q2 		$15.3K Sell
750
-148
-16% -$3.16K ﹤0.01% 2205
2025
Q1 		$24.5K Sell
898
-668
-43% -$24.8K ﹤0.01% 2106
2024
Q4 		$51.2K Buy
1,566
+644
+70% +$24.2K ﹤0.01% 1889
2024
Q3 		$20.9K Buy
+922
New +$20K ﹤0.01% 1836
2024
Q1 		– Sell
-510
Closed -$40.4K – 1922
2023
Q4 		$40.4K Sell
510
-1,266
-71% -$90.5K 0.01% 1269
2023
Q3 		$123K Buy
+1,776
New +$173K 0.02% 1154
2022
Q4 		– Sell
-915
Closed -$61K – 1198
2022
Q3 		$61K Sell
915
-380
-29% -$32.7K 0.02% 1007
2022
Q2 		$97K Buy
1,295
+118
+10% +$13.8K 0.04% 653
2022
Q1 		$172K Buy
+1,177
New +$250K 0.08% 442

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

XTX Topco's CUE Position: Q2 2026 in Review

XTX Topco sold out of Cue Biopharma (CUE) in Q2 2026, closing a stake of 504 shares — an estimated $3.48K sold.

XTX Topco first reported a position in CUE in Q1 2022 and held it in 11 quarters. The position peaked at $172K in Q1 2022. 49 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • XTX Topco reported no remaining Cue Biopharma position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 504 Cue Biopharma shares in Q2 2026, an estimated $3.48K.
  • XTX Topco first reported a position in Cue Biopharma in Q1 2022 and held it in 11 quarters.
  • XTX Topco's Cue Biopharma position peaked at $172K in Q1 2022.
  • 49 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.